English
Specials
    Upgrade
    MoneycontrolBe a PRO
    Moneycontrol PRO
    Upcoming Event:Attend Algo Convention Live, 2 Days & 12+ Speakers at best offer Rs.999/-, exclusive for Moneycontrol Pro subscribers. Register now!
    you are here: HomeNewsBusinessMoneycontrol Research

    Pharma: Trump’s executive orders may possibly provide better market access opportunities

    Indian drugmakers such as Cipla, Cadila, Lupin, Dr Reddy’s, Sun Pharma and a few small-sized pharma companies such as Laurus Labs may benefit from a likely revamp of US medicare

    Anubhav Sahu
    July 27, 2020 / 08:06 PM IST
    Pharma: Trump’s executive orders may possibly provide better market access opportunities

    Bharat Immunologicals & Biologicals Corporation | In the last four months, the stock price has risen 444 percent to Rs 31.34 per share from Rs 5.76 per share on March 27, 2020.

    PRO Only Highlights
    -      Quarterly performance largely backed by improved realisations
    -      Medium-term triggers China plus and protectionist measures for tyre industry
    -      Valuations not inexpensive; but improved medium-term outlook

    Anubhav Sahu Moneycontrol Research Highlights - Executive orders aimed at reducing drug prices by squeezing middlemen - To cap drug prices based on prices in economically comparable countries - Orders likely to have a lesser impact on generic players - Any positive outcome on market access front can benefit Indian pharma - Companies to watch: Cipla, Cadila, Lupin, Dr Reddy’s, Sun Pharma, Laurus and Biocon President Donald Trump’s executive orders, aimed at substantially reducing drug prices for the US residents, underscore the campaign pitch of the next election. Pharma pricing has...

    • PRO Panorama

      Moneycontrol Pro Panorama | GST: A simple, reliable tax still a distant dream?

      May 20, 2022 / 04:41 PM IST

      In today’s edition of Moneycontrol Pro Panorama: A peek into Strategy Lab, ITC makes it to Weekly Tactical, wide canvas for Nazara, shock proof your portfolio and more

      Read Now
    • PRO Weekender

      Moneycontrol Pro Weekender | People’s Bank of China rides to the rescue 

      May 21, 2022 / 10:10 AM IST

      The central bank of China – an outlier in these times of quantitative tightening – has eased its policy to salvage the Chinese economy. And the messaging is not lost on global growth

      Read Now

    To read the full story, Subscribe to Moneycontrol PRO

    Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

    View Plans

    Already a member? Sign in

    Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

    50% OFF

    What Do You Get

    • Ad free experience

      Experience a non-intrusive navigation and faster response in the ad free mode

    • Sharpest Opinions

      Access to 230+ exclusive stories per month from our editorial and Experts

    • +

      Have a Global edge with access to content from world renowned experts and journalist

    • Actionable Insights

      Access to 40+ weekly investment ideas including 4 daily technical calls

    • Virtual Events

      Exclusive access to live webinars from market experts on trading and investment strategies

    • Newsletters

      Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

    View Offers

    Get upto 50% discount on limited period offers